Cargando…
Decitabine salvage for TP53-mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapy
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244807/ https://www.ncbi.nlm.nih.gov/pubmed/35236053 http://dx.doi.org/10.3324/haematol.2021.280153 |
| _version_ | 1784738604836192256 |
|---|---|
| author | Ferraro, Francesca Gruszczynska, Agata Ruzinova, Marianna B. Miller, Christopher A. Percival, Mary Elizabeth Uy, Geoffrey L. Pusic, Iskra Jacoby, Meagan A. Christopher, Mathew J. Kim, Miriam Y. Westervelt, Peter Cashen, Amanda F. Schroeder, Mark A. DiPersio, John F. Abboud, Camille N. Wartman, Lukas D. Gao, Feng Link, Daniel C. Ley, Timothy J. Welch, John S. |
| author_facet | Ferraro, Francesca Gruszczynska, Agata Ruzinova, Marianna B. Miller, Christopher A. Percival, Mary Elizabeth Uy, Geoffrey L. Pusic, Iskra Jacoby, Meagan A. Christopher, Mathew J. Kim, Miriam Y. Westervelt, Peter Cashen, Amanda F. Schroeder, Mark A. DiPersio, John F. Abboud, Camille N. Wartman, Lukas D. Gao, Feng Link, Daniel C. Ley, Timothy J. Welch, John S. |
| author_sort | Ferraro, Francesca |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9244807 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92448072022-07-07 Decitabine salvage for TP53-mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapy Ferraro, Francesca Gruszczynska, Agata Ruzinova, Marianna B. Miller, Christopher A. Percival, Mary Elizabeth Uy, Geoffrey L. Pusic, Iskra Jacoby, Meagan A. Christopher, Mathew J. Kim, Miriam Y. Westervelt, Peter Cashen, Amanda F. Schroeder, Mark A. DiPersio, John F. Abboud, Camille N. Wartman, Lukas D. Gao, Feng Link, Daniel C. Ley, Timothy J. Welch, John S. Haematologica Letter to the Editor Fondazione Ferrata Storti 2022-03-03 /pmc/articles/PMC9244807/ /pubmed/35236053 http://dx.doi.org/10.3324/haematol.2021.280153 Text en Copyright© 2022 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letter to the Editor Ferraro, Francesca Gruszczynska, Agata Ruzinova, Marianna B. Miller, Christopher A. Percival, Mary Elizabeth Uy, Geoffrey L. Pusic, Iskra Jacoby, Meagan A. Christopher, Mathew J. Kim, Miriam Y. Westervelt, Peter Cashen, Amanda F. Schroeder, Mark A. DiPersio, John F. Abboud, Camille N. Wartman, Lukas D. Gao, Feng Link, Daniel C. Ley, Timothy J. Welch, John S. Decitabine salvage for TP53-mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapy |
| title | Decitabine salvage for TP53-mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapy |
| title_full | Decitabine salvage for TP53-mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapy |
| title_fullStr | Decitabine salvage for TP53-mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapy |
| title_full_unstemmed | Decitabine salvage for TP53-mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapy |
| title_short | Decitabine salvage for TP53-mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapy |
| title_sort | decitabine salvage for tp53-mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapy |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244807/ https://www.ncbi.nlm.nih.gov/pubmed/35236053 http://dx.doi.org/10.3324/haematol.2021.280153 |
| work_keys_str_mv | AT ferrarofrancesca decitabinesalvagefortp53mutatedrelapsedrefractoryacutemyeloidleukemiaaftercytotoxicinductiontherapy AT gruszczynskaagata decitabinesalvagefortp53mutatedrelapsedrefractoryacutemyeloidleukemiaaftercytotoxicinductiontherapy AT ruzinovamariannab decitabinesalvagefortp53mutatedrelapsedrefractoryacutemyeloidleukemiaaftercytotoxicinductiontherapy AT millerchristophera decitabinesalvagefortp53mutatedrelapsedrefractoryacutemyeloidleukemiaaftercytotoxicinductiontherapy AT percivalmaryelizabeth decitabinesalvagefortp53mutatedrelapsedrefractoryacutemyeloidleukemiaaftercytotoxicinductiontherapy AT uygeoffreyl decitabinesalvagefortp53mutatedrelapsedrefractoryacutemyeloidleukemiaaftercytotoxicinductiontherapy AT pusiciskra decitabinesalvagefortp53mutatedrelapsedrefractoryacutemyeloidleukemiaaftercytotoxicinductiontherapy AT jacobymeagana decitabinesalvagefortp53mutatedrelapsedrefractoryacutemyeloidleukemiaaftercytotoxicinductiontherapy AT christophermathewj decitabinesalvagefortp53mutatedrelapsedrefractoryacutemyeloidleukemiaaftercytotoxicinductiontherapy AT kimmiriamy decitabinesalvagefortp53mutatedrelapsedrefractoryacutemyeloidleukemiaaftercytotoxicinductiontherapy AT westerveltpeter decitabinesalvagefortp53mutatedrelapsedrefractoryacutemyeloidleukemiaaftercytotoxicinductiontherapy AT cashenamandaf decitabinesalvagefortp53mutatedrelapsedrefractoryacutemyeloidleukemiaaftercytotoxicinductiontherapy AT schroedermarka decitabinesalvagefortp53mutatedrelapsedrefractoryacutemyeloidleukemiaaftercytotoxicinductiontherapy AT dipersiojohnf decitabinesalvagefortp53mutatedrelapsedrefractoryacutemyeloidleukemiaaftercytotoxicinductiontherapy AT abboudcamillen decitabinesalvagefortp53mutatedrelapsedrefractoryacutemyeloidleukemiaaftercytotoxicinductiontherapy AT wartmanlukasd decitabinesalvagefortp53mutatedrelapsedrefractoryacutemyeloidleukemiaaftercytotoxicinductiontherapy AT gaofeng decitabinesalvagefortp53mutatedrelapsedrefractoryacutemyeloidleukemiaaftercytotoxicinductiontherapy AT linkdanielc decitabinesalvagefortp53mutatedrelapsedrefractoryacutemyeloidleukemiaaftercytotoxicinductiontherapy AT leytimothyj decitabinesalvagefortp53mutatedrelapsedrefractoryacutemyeloidleukemiaaftercytotoxicinductiontherapy AT welchjohns decitabinesalvagefortp53mutatedrelapsedrefractoryacutemyeloidleukemiaaftercytotoxicinductiontherapy |